These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1080556)

  • 41. Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells.
    Farrant J; Bryant AE; Lever AM; Edwards AJ; Knight SC; Webster AD
    Clin Exp Immunol; 1985 Jul; 61(1):189-94. PubMed ID: 3876180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.
    Callard RE; Smith SH; Herbert J; Morgan G; Padayachee M; Lederman S; Chess L; Kroczek RA; Fanslow WC; Armitage RJ
    J Immunol; 1994 Oct; 153(7):3295-306. PubMed ID: 7916370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymoma.
    Waldmann TA; Broder S; Durm M; Blackman M; Krakauer R; Meade B
    Trans Assoc Am Physicians; 1975; 88():120-34. PubMed ID: 1083579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig.
    Topham DJ; Tripp RA; Hamilton-Easton AM; Sarawar SR; Doherty PC
    J Immunol; 1996 Oct; 157(7):2947-52. PubMed ID: 8816401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chorioretinitis with a combined defect in T and B lymphocytes and granulocytes. A new syndrome successfully treated with dialyzable leukocyte extracts (transfer factor).
    Kyong CU; Wilson GB; Fudenberg HH; Goust JM; Richardson P; Echerd J
    Am J Med; 1980 Jun; 68(6):955-61. PubMed ID: 6992573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab--for how long?
    Barmettler S; Price C
    J Allergy Clin Immunol; 2015 Nov; 136(5):1407-9. PubMed ID: 26277594
    [No Abstract]   [Full Text] [Related]  

  • 48. Isolation of helper T cells from the peripheral blood of normal donors, using serum from a patient with agammaglobulinemia.
    Strelkauskas AJ; Donnan GG; Andrew JA
    Clin Immunol Immunopathol; 1981 Nov; 21(2):267-73. PubMed ID: 6975194
    [No Abstract]   [Full Text] [Related]  

  • 49. Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis.
    Wagner DK; Marti GE; Jaffe ES; Straus SE; Nelson DL; Fleisher TA
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):143-8. PubMed ID: 2759712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transfer factor, sarcoidosis and cellular immunity.
    Platz P; Grob PJ; Jonsson V; Lorenzen I; Thomsen M; Thomsen M
    Acta Pathol Microbiol Scand C; 1976 Feb; 84(1):68-70. PubMed ID: 1083624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Light and heavy chain components of gamma globulins in urines of normal persons and patients with agammaglobulinemia.
    Vaughan JH; Jacox RF; Gray BA
    J Clin Invest; 1967 Feb; 46(2):266-79. PubMed ID: 4163635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paralytic poliomyelitis in a child with agammaglobulinemia.
    Abo W; Chiba S; Yamanaka T; Nakao T; Hara M; Tagaya I
    Eur J Pediatr; 1979 Sep; 132(1):11-6. PubMed ID: 315313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic heterogeneity in X-linked infantile agammaglobulinemia with in vitro monocyte suppression of immunoglobulin synthesis.
    Krantman HJ; Saxon A; Stevens RH; Stiehm ER
    Clin Immunol Immunopathol; 1981 Aug; 20(2):170-8. PubMed ID: 6973439
    [No Abstract]   [Full Text] [Related]  

  • 54. Transfer factor and repeated otitis media.
    Kaminkova J; Lange CF
    Cell Immunol; 1984 Nov; 89(1):259-64. PubMed ID: 6333288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient hypogammaglobulinemia of infancy.
    Górski A; Korczak-Kowalska G; Gaciong Z; Paczek L
    N Engl J Med; 1982 Apr; 306(15):939-40. PubMed ID: 6977720
    [No Abstract]   [Full Text] [Related]  

  • 56. Transfer factor therapy in patients with cancer.
    Vetto RM; Burger DR; Nolte JE; Vandenbark AA; Baker HW
    Cancer; 1976 Jan; 37(1):90-7. PubMed ID: 1247971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial immunologic reconstitution of a patient with acquired agammaglobulinemia: a transient phenomenon accompanying therapeutic plasmapheresis.
    Wenz B; Rubinstein A
    Blood; 1982 Feb; 59(2):233-5. PubMed ID: 6976807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transfer factor--a new form for immunotherapy.
    Hanson LA
    Acta Med Scand; 1975; 198(1-2):1-3. PubMed ID: 1080947
    [No Abstract]   [Full Text] [Related]  

  • 59. Third international symposium on transfer factor.
    Kirkpatrick CH; Khan A; Hill NO
    Cell Immunol; 1979 Aug; 46(1):184-6. PubMed ID: 314845
    [No Abstract]   [Full Text] [Related]  

  • 60. A gamma-globulinemia.
    ANAND BR
    Indian J Med Sci; 1959 Jun; 13(6):493-501. PubMed ID: 13672635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.